Torsten Hoybye Regueira
Technik-/Wissenschafts-/F&E-Leiter bei AQUAPORIN A/S
Profil
Torsten Hoybye Bak Regueira is the founder of MycoTeQ A, a company founded in 2006.
He held the title of Chief Scientific Officer from 2009 to 2012.
Currently, Dr. Regueira is the Chief Technology Officer at Aquaporin A.
He has also worked as a Principal at the Technical University of Denmark.
Aktive Positionen von Torsten Hoybye Regueira
| Unternehmen | Position | Beginn |
|---|---|---|
| AQUAPORIN A/S | Technik-/Wissenschafts-/F&E-Leiter | 02.02.2024 |
Ehemalige bekannte Positionen von Torsten Hoybye Regueira
| Unternehmen | Position | Ende |
|---|---|---|
MycoTeQ A/S
 MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Gründer | 02.04.2012 |
| Technical University of Denmark | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AQUAPORIN A/S | Producer Manufacturing |
| Private Unternehmen | 1 |
|---|---|
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology MycoTeQ is working to ease the discovery process for the pharmaceutical industry in order to ensure a steady flow of new chemical entities into the pipelines of this industry. The aspiration of MycoTeQ is to build a healthy business and become the world leading external provider of new chemical entities from micro fungi. In order to succeed on these ambitious targets MycoTeQ will adhere to the highest professional and scientific standards and seek to build strong and long-lasting relationships with its partners and customers. The company was founded in October 2006 and is headquartered in Copenhagen, Denmark. | Health Technology |
